Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (KCa3.1) in endothelial cells to promote angiogenesis.
Peptide Lv is a small endogenous secretory peptide that is expressed in various tissues and conserved across different species. Patients with diabetic retinopathy, an ocular disease with pathological angiogenesis, have upregulated peptide Lv in their retinas. The pro-angiogenic activity of peptide L...
Main Authors: | Dylan L Pham, Autumn Niemi, Michael L Ko, Gladys Y P Ko |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0276744 |
Similar Items
-
Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (KCa3.1) in endothelial cells to promote angiogenesis
by: Dylan L. Pham, et al.
Published: (2022-01-01) -
Peptide Lv Promotes Trafficking and Membrane Insertion of K<sub>Ca</sub>3.1 through the MEK1–ERK and PI3K–Akt Signaling Pathways
by: Dylan L. Pham, et al.
Published: (2023-06-01) -
LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells
by: Concetta Caglioti, et al.
Published: (2022-01-01) -
Crystal structure of potassium calcium bismuthide, KCaBi
by: Hirt H., et al.
Published: (2003-03-01) -
Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis
by: Liheng Shi, et al.
Published: (2019-11-01)